Moore Capital Management, LP Revolution Medicines, Inc. Transaction History
Moore Capital Management, LP
- $4.85 Billion
- Q3 2024
A detailed history of Moore Capital Management, LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 55,600 shares of RVMD stock, worth $3.19 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
55,600
Previous 55,600
-0.0%
Holding current value
$3.19 Million
Previous $2.16 Million
16.78%
% of portfolio
0.05%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
262Shares Held
161MCall Options Held
236KPut Options Held
363K-
Vanguard Group Inc Valley Forge, PA14.9MShares$855 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$769 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$654 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$649 Million2.58% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$434 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.03B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...